annual EBITDA:
-$199.81M-$73.87M(-58.65%)Summary
- As of today (September 16, 2025), PRAX annual EBITDA is -$199.81 million, with the most recent change of -$73.87 million (-58.65%) on December 31, 2024.
- During the last 3 years, PRAX annual EBITDA has fallen by -$32.66 million (-19.54%).
- PRAX annual EBITDA is now -660.47% below its all-time high of -$26.27 million, reached on December 31, 2018.
Performance
PRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$76.02M-$1.34M(-1.79%)Summary
- As of today (September 16, 2025), PRAX quarterly EBITDA is -$76.02 million, with the most recent change of -$1.34 million (-1.79%) on June 30, 2025.
- Over the past year, PRAX quarterly EBITDA has dropped by -$38.64 million (-103.37%).
- PRAX quarterly EBITDA is now -915.78% below its all-time high of -$7.48 million, reached on December 31, 2019.
Performance
PRAX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$271.35M-$38.64M(-16.60%)Summary
- As of today (September 16, 2025), PRAX TTM EBITDA is -$271.35 million, with the most recent change of -$38.64 million (-16.60%) on June 30, 2025.
- Over the past year, PRAX TTM EBITDA has dropped by -$139.10 million (-105.17%).
- PRAX TTM EBITDA is now -2449.36% below its all-time high of -$10.64 million, reached on September 30, 2019.
Performance
PRAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.6% | -103.4% | -105.2% |
| 3 y3 years | -19.5% | -26.1% | -16.8% |
| 5 y5 years | -458.9% | -557.6% | -611.3% |
PRAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.6% | +6.9% | -199.2% | at low | -115.5% | at low |
| 5 y | 5-year | -458.9% | +6.9% | -557.6% | at low | -611.3% | at low |
| alltime | all time | -660.5% | +6.9% | -915.8% | at low | -2449.4% | at low |
PRAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$76.02M(+1.8%) | -$271.35M(+16.6%) |
| Mar 2025 | - | -$74.68M(+16.9%) | -$232.71M(+16.5%) |
| Dec 2024 | -$199.81M(+58.7%) | -$63.91M(+12.6%) | -$199.81M(+22.1%) |
| Sep 2024 | - | -$56.74M(+51.8%) | -$163.59M(+23.7%) |
| Jun 2024 | - | -$37.38M(-10.5%) | -$132.26M(+1.9%) |
| Mar 2024 | - | -$41.77M(+50.8%) | -$129.73M(+3.0%) |
| Dec 2023 | -$125.94M(-41.3%) | -$27.70M(+9.0%) | -$125.94M(-9.8%) |
| Sep 2023 | - | -$25.41M(-27.1%) | -$139.59M(-11.9%) |
| Jun 2023 | - | -$34.85M(-8.2%) | -$158.38M(-13.8%) |
| Mar 2023 | - | -$37.98M(-8.1%) | -$183.80M(-14.3%) |
| Dec 2022 | -$214.57M | -$41.35M(-6.4%) | -$214.57M(-7.4%) |
| Sep 2022 | - | -$44.19M(-26.7%) | -$231.78M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$60.27M(-12.3%) | -$232.33M(+11.4%) |
| Mar 2022 | - | -$68.76M(+17.4%) | -$208.51M(+24.7%) |
| Dec 2021 | -$167.15M(+170.0%) | -$58.56M(+30.9%) | -$167.15M(+24.5%) |
| Sep 2021 | - | -$44.73M(+22.7%) | -$134.28M(+27.0%) |
| Jun 2021 | - | -$36.46M(+33.1%) | -$105.75M(+30.8%) |
| Mar 2021 | - | -$27.40M(+6.6%) | -$80.86M(+30.6%) |
| Dec 2020 | -$61.92M(+73.2%) | -$25.69M(+58.5%) | -$61.92M(+41.7%) |
| Sep 2020 | - | -$16.21M(+40.2%) | -$43.71M(+14.6%) |
| Jun 2020 | - | -$11.56M(+36.7%) | -$38.15M(+43.5%) |
| Mar 2020 | - | -$8.46M(+13.0%) | -$26.59M(+46.7%) |
| Dec 2019 | -$35.75M(+36.1%) | -$7.48M(-29.7%) | -$18.13M(+70.3%) |
| Sep 2019 | - | -$10.64M | -$10.64M |
| Dec 2018 | -$26.27M | - | - |
FAQ
- What is Praxis Precision Medicines, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. annual EBITDA year-on-year change?
- What is Praxis Precision Medicines, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. quarterly EBITDA year-on-year change?
- What is Praxis Precision Medicines, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. TTM EBITDA year-on-year change?
What is Praxis Precision Medicines, Inc. annual EBITDA?
The current annual EBITDA of PRAX is -$199.81M
What is the all time high annual EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high annual EBITDA is -$26.27M
What is Praxis Precision Medicines, Inc. annual EBITDA year-on-year change?
Over the past year, PRAX annual EBITDA has changed by -$73.87M (-58.65%)
What is Praxis Precision Medicines, Inc. quarterly EBITDA?
The current quarterly EBITDA of PRAX is -$76.02M
What is the all time high quarterly EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high quarterly EBITDA is -$7.48M
What is Praxis Precision Medicines, Inc. quarterly EBITDA year-on-year change?
Over the past year, PRAX quarterly EBITDA has changed by -$38.64M (-103.37%)
What is Praxis Precision Medicines, Inc. TTM EBITDA?
The current TTM EBITDA of PRAX is -$271.35M
What is the all time high TTM EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high TTM EBITDA is -$10.64M
What is Praxis Precision Medicines, Inc. TTM EBITDA year-on-year change?
Over the past year, PRAX TTM EBITDA has changed by -$139.10M (-105.17%)